Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Cancer. 2012 Apr 19;118(22):5663–5670. doi: 10.1002/cncr.27563

Figure 1.

Figure 1

The topotecan lactone clearance rate increases with age in a sigmoidal manner. Points represent individual clearance rates on day 1 of each cycle in which a pharmacokinetic study was performed. The curve and shaded region represent the median and 90% prediction interval determined by the nonlinear mixed-effects model.